02 9541 3500NanoAssemblr Blaze
NanoAssemblr Blaze is designed to formulate nanomedicine batches from 10mL to 1L, necessary for advanced preclinical studies.
NanoAssemblr Blaze
NanoAssemblr Blaze is designed to formulate nanomedicine batches from 10mL to 1L, necessary for advanced preclinical studies.
| Manufacturer | Precision Nanosystems |
|---|---|
| Product Series | NanoAssemblr platform |
| Measurement principle | Emulsion and Liposome Processing |
| Application | Nanoparticle formulation |
| Formulation volume | 10 mL to 1 L per batch |
Product Overview
NanoAssemblr Blaze enables the manufacture of upto one litre of highly uniform nanoparticles for preclinical testing. The NanoAssemblr Blaze was developed to bridge the gap between nanoparticle discovery and clinical development. The dynamic volume range allows researchers to use the NanoAssemblr Blaze for nanoparticle discovery, preclinical toxicology testing and for early Chemistry, Manufacturing and Controls (CMC) studies.
The system utilises the latest microfluidic technology with continuous flow pumping through a proprietary microfluidic cartridge to produce large volumes of identical nanoparticles, between 10 mL and 1 L per batch. The process ensures the self-assembly of uniform particles with controllable and reproducible results.
The NanoAssemblr Blaze brings large batch nanoparticle studies in-house, and transfers small or lab-scale formulations seamlessly into large volumes. Nanoparticles made on the lower-volume NanoAssemblr Benchtop instrument scale seamlessly to the NanoAssemblr Blaze and show equivalent size and polydispersity in siRNA nanoparticles. With minimum process development, the NanoAssemblr Blaze accelerates the transfer of nanoparticle candidates towards clinical development.
- Benefits
- Applications
- Accessories
Benefits
Particle Size Control: Combining reproducible microfluidics with precise fluid injection allows users to efficiently find and dial-in the optimal conditions for nanoparticle formation.
Efficient Drug Loading: Improved drug loading or encapsulation efficiency compared to conventional methods.
Scalable Production: The continuous flow microfluidic process can be scaled up by increasing total volume injected through a single mixer, or by employing multiple mixer in parallel without affecting the underlying conditions of nano particle synthesis. This allows formulations to be optimised at bench scales, and scaled up with little to no re-optimisation at each change in batch size.
Versatile: Suitable for creating a variety of different particles including:
• Biodegradable polymer nanoparticles (ex: PLGA)
• Amphiphilic block co-polymer micelles (ex: PEG-PLA)
• Dendrimer nanoparticles
• Polymer-drug conjugates
• Nucleic acid Lipid Nanoparticles (LNP)
• Lipsomes, Emulsions, Organic/ Inorganic Nanoparticles
Applications
Gene delivery via high in vivo cell transfection efficiency
Nanoparticle design
Drug development
Lipid nanoparticles formulation
Liposome encapsulation
Polymeric nanoparticles
Accessories
NanoAssemblr Blaze Cartridges with inline dilution
Cartridges allow for the manufacture of nanoparticles across a range of volumes. These disposable cartridges are single use and allow for formulation of a variety of nanoparticles via nanoprecipitation.
Related products
NanoAssemblr Spark
NanoAssemblr Spark enables the manufacture of ultra-low nanoparticle volumes between 25 – 250 μL in less than 10 seconds, which is ideal for low-cost formulation of scarce materials.
Find out more
Avestin Emulsiflex B15
The Avestin Emulsiflex B15 cell disruptor is an air powered, French Press style, high pressure Homogeniser that rapidly disrupts cells while avoiding over processing and protein damage.
Find out moreProduct Enquiry
To enquire about this product, please send through your details below and one of our product specialists will be in touch to discuss your requirements.
Please note, information requests are only applicable to Australia, New Zealand, Papua New Guinea and Fiji.